2.71
price up icon11.52%   0.28
after-market Handel nachbörslich: 2.95 0.24 +8.86%
loading

Dogwood Therapeutics Inc Aktie (DWTX) Neueste Nachrichten

pulisher
Nov 20, 2024

Dogwood Therapeutics Faces Potential Asset Loss and Financial Risks Amid Sealbond Repurchase Option - MSN

Nov 20, 2024
pulisher
Nov 18, 2024

Dogwood Therapeutics, Inc. Announces Low Dose IMC-2 Treatment Reduces Long-COVID Related Fatigue and Sleep Disturbance in an Investigator-Initiated Study - The Manila Times

Nov 18, 2024
pulisher
Nov 18, 2024

Dogwood Therapeutics, Inc. Announces Low Dose IMC-2 - GlobeNewswire

Nov 18, 2024
pulisher
Nov 18, 2024

Dogwood Reports Positive Long-COVID Trial Data; Low-Dose IMC-2 Shows Promise in Fatigue Reduction | DWTX Stock News - StockTitan

Nov 18, 2024
pulisher
Nov 14, 2024

Zacks Small Cap Has Negative Outlook of DWTX FY2024 Earnings - Defense World

Nov 14, 2024
pulisher
Nov 12, 2024

Barclays Forecasts Strong Price Appreciation for Arista Networks (NYSE:ANET) Stock - Defense World

Nov 12, 2024
pulisher
Nov 12, 2024

Dogwood Therapeutics Announces Third Quarter Financial ResultsOn November 7, 2024, Dogwood Therapeutics, Inc. (Nasdaq: DWTX) disclosed its financial performance for the third quarter ending September 30, 2024. The company, newly formed in Octob - Defense World

Nov 12, 2024
pulisher
Nov 11, 2024

DWTX: Phase 2 Long COVID Results Expected Soon - Smartkarma

Nov 11, 2024
pulisher
Nov 11, 2024

U.S. Stock market top losers:1847 Holdings LLC drop by 41.56%, Interactive Strength Inc. declined by 27.76% during mid day trading - Business Upturn

Nov 11, 2024
pulisher
Nov 11, 2024

Pre-market Movers: REVB, CDIO, SMLR, DWTX... - RTTNews

Nov 11, 2024
pulisher
Nov 09, 2024

White Cliff Minerals Director Increases Shareholding - MSN

Nov 09, 2024
pulisher
Nov 08, 2024

Dogwood Therapeutics Reports Q3 2024 Financial Results - TipRanks

Nov 08, 2024
pulisher
Nov 07, 2024

Dogwood Therapeutics Announces Third Quarter 2024 Financial Results - GlobeNewswire

Nov 07, 2024
pulisher
Nov 05, 2024

Virios Therapeutics Announces Submission of Final Toxicology Results to Support Proposed Phase 3 Program for Novel Therapy to Treat Fibromyalgia - Marketscreener.com

Nov 05, 2024
pulisher
Nov 05, 2024

Craig-Hallum Initiates Coverage of PolyPid (PYPD) with Buy Recommendation - MSN

Nov 05, 2024
pulisher
Nov 05, 2024

Peregrine Gold Ltd Confirms Prospectus Lodgement for Security Issue - MSN

Nov 05, 2024
pulisher
Nov 04, 2024

Virios Therapeutics to Report First Quarter 2023 Financial Results on Thursday, May 11, 2023 - Marketscreener.com

Nov 04, 2024
pulisher
Nov 01, 2024

Flutter Entertainment Files Block Listing Application for Ordinary Shares - Defense World

Nov 01, 2024
pulisher
Nov 01, 2024

Nano Nuclear Energy Inc. Completes Full Exercise of Over-Allotment Option, Generating Approximately $37.7 Million in Net Proceeds - Defense World

Nov 01, 2024
pulisher
Nov 01, 2024

AgEagle Aerial Systems Appoints Kevin Lowdermilk as Independent Director - Defense World

Nov 01, 2024
pulisher
Oct 31, 2024

Dogwood Therapeutics to Report Third Quarter 2024 Financial - GlobeNewswire

Oct 31, 2024
pulisher
Oct 31, 2024

DWTXDogwood Therapeutics, Inc. Latest Stock News & Market Updates - StockTitan

Oct 31, 2024
pulisher
Oct 30, 2024

Dogwood Therapeutics regains Nasdaq compliance - Investing.com

Oct 30, 2024
pulisher
Oct 30, 2024

Dogwood Therapeutics regains Nasdaq compliance By Investing.com - Investing.com UK

Oct 30, 2024
pulisher
Oct 30, 2024

Dogwood Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement - GlobeNewswire

Oct 30, 2024
pulisher
Oct 24, 2024

Virios Therapeutics’ Study Featured in Peer-Reviewed Journal Publication Highlighting Association of Herpes Simplex Type 1 Viral Infection with Common Gastrointestinal Disorders, Including in Patients with Comorbid Fibromyalgia - Marketscreener.com

Oct 24, 2024
pulisher
Oct 23, 2024

U.S. shares higher at close of trade; Dow Jones Industrial Average up 1.03% - MSN

Oct 23, 2024
pulisher
Oct 22, 2024

Dogwood Therapeutics : Corporate Presentation (Virios DWTX Inc. Corporate Overview Q4 2024) - Marketscreener.com

Oct 22, 2024
pulisher
Oct 21, 2024

Healthpeak Properties raised to Buy at Deutsche on leasing prospects - MSN

Oct 21, 2024
pulisher
Oct 17, 2024

Dogwood Therapeutics, Inc. Expected to Earn Q3 2024 Earnings of ($1.40) Per Share (NASDAQ:DWTX) - Defense World

Oct 17, 2024
pulisher
Oct 15, 2024

Dogwood Therapeutics, Inc.DWTX: Virios Therapeutics Becomes Dogwood Therapeutics - Smartkarma

Oct 15, 2024
pulisher
Oct 15, 2024

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 1.03% - MSN

Oct 15, 2024
pulisher
Oct 14, 2024

Financial Metrics Check: Dogwood Therapeutics Inc. (DWTX)’s Ratios for Trailing Twelve Months - The Dwinnex

Oct 14, 2024
pulisher
Oct 13, 2024

VIRIOS THERAPEUTICS, INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits (form 8-K) - Marketscreener.com

Oct 13, 2024
pulisher
Oct 12, 2024

Dogwood Therapeutics (DWTX) Stock Chart and Price History 2024 - MarketBeat

Oct 12, 2024
pulisher
Oct 11, 2024

Virios Therapeutics to Report Second Quarter 2023 Financial Results on Thursday, August 10, 2023 - Marketscreener.com

Oct 11, 2024
pulisher
Oct 11, 2024

Virios Therapeutics Announces Closing of $1.7 Million Public Offering of Common Stock to Commence Preparations for Planned IMC-2 Long-COVID Phase 2b Study - Marketscreener.com

Oct 11, 2024
pulisher
Oct 10, 2024

Virios Therapeutics to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024 - Marketscreener.com

Oct 10, 2024
pulisher
Oct 10, 2024

Virios Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update - Marketscreener.com

Oct 10, 2024
pulisher
Oct 10, 2024

United States shares higher at close of trade; Dow Jones Industrial Average up 1.03% - Investing.com India

Oct 10, 2024
pulisher
Oct 08, 2024

Virios Therapeutics shares target raised on Wex merger news - Investing.com

Oct 08, 2024
pulisher
Oct 08, 2024

New obesity treatment has this tiny co soaring 💃 - RagingBull

Oct 08, 2024
pulisher
Oct 08, 2024

Virios Therapeutics Transforms into Dogwood Therapeutics - Yahoo Finance

Oct 08, 2024
pulisher
Oct 08, 2024

CKLIFE SCIENCES Hopes to Introduce Investors for Newly Merged Dogwood (DWTX.US) - AASTOCKS.com

Oct 08, 2024
pulisher
Oct 08, 2024

Virios Therapeutics announces strategic merger and financing - Investing.com

Oct 08, 2024
pulisher
Oct 07, 2024

Virios Therapeutics, Inc. and Wex Pharmaceuticals, Inc. to Combine to Form Dogwood Therapeutics, Inc. - Orrick

Oct 07, 2024
pulisher
Oct 07, 2024

Virios Therapeutics And Wex Pharmaceuticals To Merge - citybiz

Oct 07, 2024
pulisher
Oct 07, 2024

VIRI Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Virios Therapeutics, Inc. Is Fair to Shareholders - Marketscreener.com

Oct 07, 2024
pulisher
Oct 07, 2024

Virios Therapeutics, Wex Pharmaceuticals announce business combination agreement - TipRanks

Oct 07, 2024
pulisher
Oct 07, 2024

Virios, and Wex Pharmaceuticals report business combination to form Dogwood Therapeutics - MSN

Oct 07, 2024
pulisher
Oct 07, 2024

Virios Therapeutics, Inc. Announces Management Changes - Marketscreener.com

Oct 07, 2024
pulisher
Oct 07, 2024

Conjoint Inc. Enters into the Loan Agreement with the Virios Therapeutics, Inc - Marketscreener.com

Oct 07, 2024
pulisher
Oct 07, 2024

Virios Therapeutics announces strategic merger and financing By Investing.com - Investing.com UK

Oct 07, 2024
pulisher
Oct 07, 2024

Virios Therapeutics, Inc. and Wex Pharmaceuticals, Inc. - GlobeNewswire

Oct 07, 2024
pulisher
Oct 07, 2024

Virios Therapeutics, Inc. and Wex Pharmaceuticals, Inc. Announce Business Combination to Form Dogwood Therapeutics, Inc. (Nasdaq: “DWTX”) - Yahoo Finance

Oct 07, 2024
pulisher
Aug 09, 2024

Virios Therapeutics Announces Second Quarter 2024 Financial Results - Marketscreener.com

Aug 09, 2024
pulisher
May 19, 2024

Virios Therapeutics Announces Pricing of $1.7 Million Public Offering of Common Stock to Commence Preparations for Planned IMC-2 Long-COVID Phase 2b Study - Marketscreener.com

May 19, 2024
pulisher
May 17, 2024

Virios Therapeutics Announces Proposed Public Offering of Common Stock to Commence Preparations for Planned IMC-2 Long-COVID Phase 2b Study - Marketscreener.com

May 17, 2024
pulisher
Apr 01, 2024

Capital Bancorp (CBNK) to Buy Integrated Financial for $66M - Yahoo Finance

Apr 01, 2024
$70.39
price down icon 0.93%
$18.42
price down icon 1.07%
$38.25
price up icon 3.55%
$367.36
price up icon 0.83%
$194.56
price up icon 0.15%
$108.23
price up icon 5.96%
Kapitalisierung:     |  Volumen (24h):